BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 15146108)

  • 1. Toll-like receptors and immune response in allergic disease.
    Gangloff SC; Guenounou M
    Clin Rev Allergy Immunol; 2004 Apr; 26(2):115-25. PubMed ID: 15146108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors and T-helper-1/T-helper-2 responses.
    Dabbagh K; Lewis DB
    Curr Opin Infect Dis; 2003 Jun; 16(3):199-204. PubMed ID: 12821808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity.
    Kurt-Jones EA; Sandor F; Ortiz Y; Bowen GN; Counter SL; Wang TC; Finberg RW
    J Endotoxin Res; 2004; 10(6):419-24. PubMed ID: 15588425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR9-based immunotherapy for the treatment of allergic diseases.
    Farrokhi S; Abbasirad N; Movahed A; Khazaei HA; Pishjoo M; Rezaei N
    Immunotherapy; 2017 Mar; 9(4):339-346. PubMed ID: 28303762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
    Chisholm D; Libet L; Hayashi T; Horner AA
    J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy.
    Kirtland ME; Tsitoura DC; Durham SR; Shamji MH
    Front Immunol; 2020; 11():599083. PubMed ID: 33281825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses.
    Kirschning CJ; Bauer S
    Int J Med Microbiol; 2001 Sep; 291(4):251-60. PubMed ID: 11680785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance.
    Ito T; Amakawa R; Fukuhara S
    Hum Immunol; 2002 Dec; 63(12):1120-5. PubMed ID: 12480255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma.
    Redecke V; Häcker H; Datta SK; Fermin A; Pitha PM; Broide DH; Raz E
    J Immunol; 2004 Mar; 172(5):2739-43. PubMed ID: 14978071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of pathogen-associated molecular patterns by TLR family.
    Akira S; Hemmi H
    Immunol Lett; 2003 Jan; 85(2):85-95. PubMed ID: 12527213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.
    Querec T; Bennouna S; Alkan S; Laouar Y; Gorden K; Flavell R; Akira S; Ahmed R; Pulendran B
    J Exp Med; 2006 Feb; 203(2):413-24. PubMed ID: 16461338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.
    Heil F; Ahmad-Nejad P; Hemmi H; Hochrein H; Ampenberger F; Gellert T; Dietrich H; Lipford G; Takeda K; Akira S; Wagner H; Bauer S
    Eur J Immunol; 2003 Nov; 33(11):2987-97. PubMed ID: 14579267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Responses with participation of toll-like receptors in protective immunity and in pathologic states].
    Skivka LM; Pozur VV
    Ukr Biokhim Zh (1999); 2008; 80(3):5-20. PubMed ID: 18959023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyD88-dependent induction of allergic Th2 responses to intranasal antigen.
    Piggott DA; Eisenbarth SC; Xu L; Constant SL; Huleatt JW; Herrick CA; Bottomly K
    J Clin Invest; 2005 Feb; 115(2):459-67. PubMed ID: 15650773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity: from lymphocyte mitogens to Toll-like receptors and back.
    Coutinho A; Poltorack A
    Curr Opin Immunol; 2003 Dec; 15(6):599-602. PubMed ID: 14630190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.